硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
人 53BP1 抗体对
试剂盒

人 53BP1 抗体对

01AB00440

Tumor protein p53 binding protein 1 (TP53BP1) is a crucial protein involved in DNA double-strand break repair, particularly in promoting non-homologous end joining (NHEJ) pathways. It interacts with damaged chromatin, recognizing specific epigenetic markers, and plays a role in telomere dynamics and class-switch recombination during antibody genesis. TP53BP1 forms a complex with RIF1, inhibiting DNA end resection and competing with BRCA1-CtIP to determine the repair pathway choice. The protein contains multiple functional domains and exists in three cellular pools: cytoplasmic, nuclear, and DNA repair foci. TP53BP1 also binds to the p53 protein, regulating cell cycle progression and proliferation. In terms of disease relevance, TP53BP1 is underexpressed in most cases of triple-negative breast cancer. Additionally, as individuals age, the recruitment of 53BP1 to double-strand breaks during the G1 phase becomes deficient, potentially contributing to the aging process through error-prone repair mechanisms.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
TP53BP1
蛋白别名
tumor protein p53 binding protein 1; 53BP1
UniProt
Q12888
物种
Human

产品详情

靶点名称
53BP1
蛋白名称
tumor protein p53 binding protein 1
蛋白别名
TP53-binding protein 1; 53BP1; p53-binding protein 1; p53BP1
靶点基因名
TP53BP1
UniProt
Q12888
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

Tumor protein p53 binding protein 1 (TP53BP1) is a crucial protein involved in DNA double-strand break repair, particularly in promoting non-homologous end joining (NHEJ) pathways. It interacts with damaged chromatin, recognizing specific epigenetic markers, and plays a role in telomere dynamics and class-switch recombination during antibody genesis. TP53BP1 forms a complex with RIF1, inhibiting DNA end resection and competing with BRCA1-CtIP to determine the repair pathway choice. The protein contains multiple functional domains and exists in three cellular pools: cytoplasmic, nuclear, and DNA repair foci. TP53BP1 also binds to the p53 protein, regulating cell cycle progression and proliferation. In terms of disease relevance, TP53BP1 is underexpressed in most cases of triple-negative breast cancer. Additionally, as individuals age, the recruitment of 53BP1 to double-strand breaks during the G1 phase becomes deficient, potentially contributing to the aging process through error-prone repair mechanisms.